Patent US3016288A successfully refreshed from Google Patents.
Patent US4261971A successfully refreshed from Google Patents.
US4261971A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutically preparation comprising a cardiac glycoside in combination with a polymer
Assignee: Hassle AB
•
Filing: 1979-12-17
•
Granted: 1981-04-14
•
Expires: 1999-12-17
Abstract
Abstract A solid pharmaceutical preparation for administration in dosage unit form comprising a therapeutically effective cardiac glycoside, whereby each dosage unit is to comprise a plurality of bodies, each of said bodies having a pharmaceutically inert core and a layer thereon containing the glycoside and a polymer insoluble in gastric juice and soluble in intestinal juice, a process for preparing such preparation and a method of treatment employing the same.
Inventors
- 👤 Curt H. Appelgren
- 👤 Conny B. Bogentoft
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 08:06
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7028; A61K31/7034; A61K31/704; A61K9/00; A61K9/14; A61K9/16; A61K9/167; A61K9/1676; A61M; A61M5/00; A61M5/178; A61M5/31; A61M5/32; A61M5/3205; A61M5/3278
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
100 words
A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, characterized in that said pharmaceutical preparation is in the form of a plurality of small bodies, each body comprising a fraction of a therapeutically effective dosage of the cardiac glycoside, whereby each body has a core made up of pharmaceutically indifferent material, and on said core a layer made up of a composition comprising the cardiac glycoside and an anionic carboxylic polymer being difficultly soluble or insoluble below a given pH value in the interval of pH 4-7.5 but being soluble at a pH above said given value.
Claim 2
Dependent Claim
100 words
A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, characterized in that said pharmaceutical preparation is in the form of a plurality of small bodies, each body comprising a fraction of a therapeutically effective dosage of the cardiac glycoside, whereby each body has a core made up of pharmaceutically indifferent material, and on said core a layer made up of a composition comprising the cardiac glycoside and an anionic carboxylic polymer being difficultly soluble or insoluble below a given pH value in the interval of pH 4-7.5 but being soluble at a pH above said given value.
Claim 3
Dependent Claim
25 words
A solid pharmaceutical preparation according to claim 1 characterized in that the layer is a layer applied by spraying a solution of the components thereof.
Claim 4
Dependent Claim
102 words
A process for preparing a pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, characterized in that said pharmaceutical preparation is given the form of a plurality of small bodies, each body comprising a fraction of a therapeutically effective dosage of the cardiac glycoside, by providing a large number of cores made up of pharmaceutically indifferent material, with a layer made up of a composition comprising the cardiac glycoside and an anionic carboxylic polymer being difficultly soluble or insoluble below a given pH value in the interval of pH 4-7.5 but being soluble at a pH above said given value.
Claim 5
Dependent Claim
102 words
A process for preparing a pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, characterized in that said pharmaceutical preparation is given the form of a plurality of small bodies, each body comprising a fraction of a therapeutically effective dosage of the cardiac glycoside, by providing a large number of cores made up of pharmaceutically indifferent material, with a layer made up of a composition comprising the cardiac glycoside and an anionic carboxylic polymer being difficultly soluble or insoluble below a given pH value in the interval of pH 4-7.5 but being soluble at a pH above said given value.
Claim 6
Dependent Claim
22 words
A process according to claim 3 characterized in that the outer layer is applied by adding a solution of the components thereof.
Claim 7
Dependent Claim
15 words
A process according to claim 4 characterized in that the solution is applied by spraying.
Claim 8
Dependent Claim
21 words
A process according to claim 4 or 5 characterized in that the outer layer is applied in a fluid bed apparatus.
Claim 9
Dependent Claim
24 words
A method of treatment of cardiac disorders comprising administrating to a mammal including man a therapeutically effective dose of the preparation of claim 1.
References Cited (Backward Citations)
US2455790A
Cited
US2702264A
Cited
US2698822A
Cited
US2881085A
Cited
US2853420A
Cited
US2921883A
Cited
US2928770A
Cited
US3089824A
Cited
US3080294A
Cited
US3371015A
Cited
US3247066A
Cited
US3325365A
Cited
US3344029A
Cited
US3400185A
Cited
US3538214A
Cited
US3835221A
Cited
US3775537A
Cited
US3954959A
Cited
US4083949A
Cited
US3965255A
Cited
US4151273A
Cited
DE2651176A1
Cited
US4147768A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-04-13 | 1984-10-13 | 1985-04-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-04-13 | 1988-10-13 | 1989-04-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-04-13 | 1992-10-13 | 1993-04-14 | $7700.00 | Window Closed / Lapsed |